Last updated: 8 August 2024 at 4:33pm EST

Michael Benkowitz Net Worth




The estimated Net Worth of Michael Benkowitz is at least $15.3 Millón dollars as of 7 August 2024. Mr. Benkowitz owns over 25,000 units of United Therapeutics Corp stock worth over $6,923,800 and over the last 8 years he sold UTHR stock worth over $0. In addition, he makes $8,383,190 as President y Chief Operating Officer at United Therapeutics Corp.

Mr. Benkowitz UTHR stock SEC Form 4 insiders trading

Michael has made over 39 trades of the United Therapeutics Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 25,000 units of UTHR stock worth $2,960,250 on 7 August 2024.

The largest trade he's ever made was exercising 32,200 units of United Therapeutics Corp stock on 6 May 2024 worth over $5,258,260. On average, Michael trades about 5,078 units every 28 days since 2016. As of 7 August 2024 he still owns at least 20,000 units of United Therapeutics Corp stock.

You can see the complete history of Mr. Benkowitz stock trades at the bottom of the page.





Michael Benkowitz biography

Michael Benkowitz serves as President, Chief Operating Officer of the Company. He joined United Therapeutics in 2011 as Executive Vice President, Organizational Development. In this role, he was responsible for most companywide administrative functions, including human resources, information technology, corporate real estate and risk management, and was also responsible for many of our business development efforts and oversight of several of company key collaborations. He was promoted to President and Chief Operating Officer in June 2016, when he also became responsible for all of company commercial and medical affairs activities.

What is the salary of Michael Benkowitz?

As the President y Chief Operating Officer of United Therapeutics Corp, the total compensation of Michael Benkowitz at United Therapeutics Corp is $8,383,190. There are 1 executives at United Therapeutics Corp getting paid more, with Martine Rothblatt having the highest compensation of $15,627,500.



How old is Michael Benkowitz?

Michael Benkowitz is 48, he's been the President y Chief Operating Officer of United Therapeutics Corp since 2016. There are 20 older and no younger executives at United Therapeutics Corp. The oldest executive at United Therapeutics Corp is Louis Sullivan, 86, who is the Independent Director.

What's Michael Benkowitz's mailing address?

Michael's mailing address filed with the SEC is C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING, MD, 20910.

Insiders trading at United Therapeutics Corp

Over the last 20 years, insiders at United Therapeutics Corp have traded over $68,910,395 worth of United Therapeutics Corp stock and bought 229,703 units worth $13,655,671 . The most active insiders traders include Martine A Rothblatt, David Zaccardelli y Roger Jeffs. On average, United Therapeutics Corp executives and independent directors trade stock every 3 days with the average trade being worth of $2,310,818. The most recent stock trade was executed by James Edgemond on 9 September 2024, trading 8,332 units of UTHR stock currently worth $991,341.



What does United Therapeutics Corp do?

united therapeutics corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. we currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! our employees can be found collaborating across the united states, europe and asia. as a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #weareunitherians



What does United Therapeutics Corp's logo look like?

United Therapeutics Corp logo

Complete history of Mr. Benkowitz stock trades at United Therapeutics Corp

Fecha
#
Empresa
Persona
Trans.
Transacción
Acciones Precio por acción Precio total Acciones después de Fuente
7 Aug 2024 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 25,000 $118.41 $2,960,250
7 Aug 2024
20,000
6 May 2024 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 32,200 $163.30 $5,258,260
6 May 2024
34,777
29 Dec 2022 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 5,000 $163.30 $816,500
29 Dec 2022
7,353
22 Dec 2022 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 8,000 $94.96 $759,680
22 Dec 2022
10,353
20 Dec 2022 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 8,000 $94.96 $759,680
20 Dec 2022
10,353
15 Dec 2022 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 8,000 $94.96 $759,680
15 Dec 2022
10,353
13 Dec 2022 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 8,000 $94.96 $759,680
13 Dec 2022
10,353
8 Dec 2022 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 8,000 $94.96 $759,680
8 Dec 2022
10,353
21 Dec 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 2,400 $61.06 $146,544
21 Dec 2021
4,635
16 Dec 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $61.06 $244,240
16 Dec 2021
6,235
14 Dec 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $61.06 $244,240
14 Dec 2021
6,235
7 Dec 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $61.06 $244,240
7 Dec 2021
6,235
23 Nov 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $61.06 $244,240
23 Nov 2021
6,235
18 Nov 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
18 Nov 2021
6,235
16 Nov 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
16 Nov 2021
6,235
11 Nov 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
11 Nov 2021
6,235
9 Nov 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
9 Nov 2021
6,235
4 Nov 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
4 Nov 2021
6,235
2 Nov 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
2 Nov 2021
6,235
28 Oct 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
28 Oct 2021
6,235
26 Oct 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
26 Oct 2021
6,235
21 Oct 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
21 Oct 2021
6,235
7 Oct 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
7 Oct 2021
6,235
23 Sep 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
23 Sep 2021
6,235
21 Sep 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
21 Sep 2021
6,235
16 Sep 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
16 Sep 2021
6,235
14 Sep 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
14 Sep 2021
6,235
9 Sep 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
9 Sep 2021
6,235
7 Sep 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
7 Sep 2021
6,235
2 Sep 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
2 Sep 2021
6,235
31 Aug 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
31 Aug 2021
6,235
26 Aug 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
26 Aug 2021
6,235
24 Aug 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
24 Aug 2021
6,235
19 Aug 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
19 Aug 2021
6,235
17 Aug 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
17 Aug 2021
6,235
12 Aug 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
12 Aug 2021
6,235
10 Aug 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
10 Aug 2021
6,235
5 Aug 2021 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 4,000 $53.83 $215,320
5 Aug 2021
6,235
2 Nov 2020 Michael Benkowitz
PRESIDENT AND COO
Uso de opción 28,200 $63.42 $1,788,444
2 Nov 2020
8,448


United Therapeutics Corp executives and stock owners

United Therapeutics Corp executives and other stock owners filed with the SEC include: